Abstract:Liver depleted of hepatic stellate cells (HSCs) is resistant to ischemia/reperfusion‐, concanavalin A‐, and acetaminophen‐induced acute injury. Whether HSCs regulate carbon tetrachloride (CCl4)‐induced acute liver injury is not known. CCl4 treatment damages pericentral hepatocytes that express CCl4‐metabolizing Cyp2E1 and activates HSCs. We investigated whether HSC‐depletion in mice transgenic for thymidine kinase under the glial fibrillary acidic protein promoter (GFAP‐TK‐Tg) confers resistance to injury and inflammation due to CCl4 rechallenge. GFAP‐TK‐Tg or wild type (WT) mice were administered 0.16 ml/kg CCl4 (3× at 3 days intervals), then 40 μg/g/day ganciclovir for 10 days. The treatment depletes ~70%–75% HSCs from GFAP‐TK‐Tg but not WT mice while the liver recovers from earlier CCl4‐induced injury. Mice were then administered CCl4, and liver injury and inflammation were determined at 24 h. HSC‐depleted and HSC‐sufficient mice showed similar CCl4‐induced hepatocyte necrosis and oxidative stress. However, increase in F4/80+ macrophages, but not CD68+ cells, was greater in CCl4 rechallenged HSC‐depleted compared to HSC‐sufficient mice. Expression of tumor necrosis factor‐α (TNF‐α), CCL2, and CXCL1 increased similarly, whereas increase in interleukin‐6 (IL6), IL1β, and IL10 expression was higher in CCl4 rechallenged HSC‐depleted compared to HSC‐sufficient mice. CCl4 rechallenge of HSC‐sufficient mice rapidly activated HSCs causing significant fibrosis with increased expression of Col1a1, transforming growth factor β1 (TGFβ1), tissue inhibitors of metalloproteinases 1 (TIMP1); increase in TIPM1 was much lower and metalloproteinases 13 (MMP13) greater in CCl4 rechallenged HSC‐depleted mice. Interestingly, hepatic recruitment of both profibrogenic (Ly6Chi) and antifibrogenic restorative (Ly6Clo) macrophages, and neutrophils was significantly greater in CCl4 rechallenged HSC‐depleted mice. These data suggest that CCl4 directly damages hepatocytes but HSCs regulate inflammation. Rapid fibrogenesis in CCl4 rechallenged HSC‐sufficient mice recovered from earlier injury indicates that even transiently activated HSCs that had reverted to the quiescent phenotype remain primed to become reactivated.

Hepatocyte-specific knockout of HIF-2α cannot alleviate carbon tetrachloride-induced liver fibrosis in mice

Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

Toll Like Receptor 2 Knock‐out Attenuates Carbon Tetrachloride (ccl4)‐induced Liver Fibrosis by Downregulating MAPK and NF‐κB Signaling Pathways

Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation

The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.

IL-8 exacerbates CCl4-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway

Aldehyde Dehydrogenase 2 Activation Ameliorates Ccl4-Induced Chronic Liver Fibrosis In Mice By Up-Regulating Nrf2/Ho-1 Antioxidant Pathway

Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease

Differential recruitment of monocyte‐derived macrophages in control and stellate cell‐depleted mice during recurrent carbon tetrachloride‐induced acute liver injury

Unc-51 Like Autophagy Activating Kinase 1 Knockout Protects Against Carbon Tetrachloride-induced Liver Fibrosis: the Role of Autophagy

Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis

Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.

Mediator subunit MED1 deficiency prevents carbon tetrachloride-induced hepatic fibrosis in mice

Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice

HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis

Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation

Systemic Infusion of FLK1+ Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis in Mice

HIF-2α drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis

Hypoxia‐inducible Factor‐dependent Production of Profibrotic Mediators by Hypoxic Hepatocytes

Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.

Sja-Let-7 Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in a Mouse Model via Col1α2